Sky Century Investment (SKYI) Interest Coverage Ratio (2024 - 2025)

Sky Century Investment's (SKYI) quarterly Interest Coverage Ratio came in at 0.07 in Q2 2025, up 51.79% on a QoQ basis from 0.15 in Q1 2025.

Sky Century Investment (SKYI) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Interest Coverage Ratio data on file, last reported at 0.07 in Q2 2025.

On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 0.07 in Q2 2025; TTM through Feb 2026 was 138.7, a 26264.63% decrease from a year earlier, with the FY2025 full-year figure at 0.6, down 39.62% from the prior year.
Interest Coverage Ratio for Q2 2025 stood at 0.07, up from 0.15 in the prior quarter.
Over the last five years, Interest Coverage Ratio for SKYI reached as high as 0.07 in Q2 2025 and fell as low as 80.15 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	13.44
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-2.81
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	0.18
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-0.07
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	0.33
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	5.11
10	Sky Century Investment	1.06 Mn	1.06 Mn	26,045.00	-

Download Data